Fig. 9: Effect of ZLDI-8 on cytotoxic activity of Etoposide or paclitaxel on MHCC97-H cell-cycle arrest. | Cell Death & Disease

Fig. 9: Effect of ZLDI-8 on cytotoxic activity of Etoposide or paclitaxel on MHCC97-H cell-cycle arrest.

From: Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells

Fig. 9

Cells, were pre-treated with ZLDI-8, were treated with IC50 concentration of Etoposide (a) or Paclitaxel (b). Then, the cells were harvested and flow cytometer was performed. Results were shown as photographs or mean ± SD. *p < 0.05 vs. Sorafenib or control; *p < 0.05 vs. ZLDI-8 or control

Back to article page